chr6-73736491-A-G
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_133493.5(CD109):āc.616A>Gā(p.Ile206Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0103 in 1,612,012 control chromosomes in the GnomAD database, including 111 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_133493.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD109 | NM_133493.5 | c.616A>G | p.Ile206Val | missense_variant | 5/33 | ENST00000287097.6 | NP_598000.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD109 | ENST00000287097.6 | c.616A>G | p.Ile206Val | missense_variant | 5/33 | 1 | NM_133493.5 | ENSP00000287097.4 | ||
CD109 | ENST00000437994.6 | c.616A>G | p.Ile206Val | missense_variant | 5/33 | 1 | ENSP00000388062.2 | |||
CD109 | ENST00000422508.6 | c.385A>G | p.Ile129Val | missense_variant | 4/32 | 1 | ENSP00000404475.2 | |||
CD109 | ENST00000649530.1 | n.588A>G | non_coding_transcript_exon_variant | 4/26 |
Frequencies
GnomAD3 genomes AF: 0.00759 AC: 1155AN: 152224Hom.: 5 Cov.: 32
GnomAD3 exomes AF: 0.00907 AC: 2262AN: 249306Hom.: 24 AF XY: 0.00949 AC XY: 1280AN XY: 134858
GnomAD4 exome AF: 0.0106 AC: 15405AN: 1459670Hom.: 107 Cov.: 30 AF XY: 0.0106 AC XY: 7697AN XY: 726220
GnomAD4 genome AF: 0.00756 AC: 1152AN: 152342Hom.: 4 Cov.: 32 AF XY: 0.00768 AC XY: 572AN XY: 74498
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | CD109: BP4, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 05, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at